Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31029
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWoodward, Michael M-
dc.contributor.authorBrodaty, Henry-
dc.contributor.authorMcCabe, Maree-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorNaismith, Sharon L-
dc.contributor.authorMorris, Philip-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorWalker, Peter-
dc.contributor.authorYates, Mark-
dc.date.accessioned2022-10-21T04:39:45Z-
dc.date.available2022-10-21T04:39:45Z-
dc.date.issued2022-
dc.identifier.citationJournal of Alzheimer's Disease: JAD 2022; 89(3): 803-809en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31029-
dc.description.abstractPrior to the usual clinical symptoms of dementia, there can be subtle changes in cognitive function that differ from the normal age-related cognitive decline, which has been termed mild cognitive impairment (MCI). The increase in the numbers of individuals with possible MCI presenting to health care professionals, notably, General Practitioners (GPs), is going to rise dramatically in the coming years. With ever increasing demands on GPs, it is therefore timely to provide information that can be accessed by health care professionals to assist them in making appropriate diagnoses and to provide the most relevant, evidence-based treatment options. We have provided a comprehensive list of recommendations that aim to address key aspects of MCI in primary care. Specifically, these relate to detection and diagnosis; sharing the diagnosis, monitoring, and follow up; practical interventions to potentially delay progression; and personalizing care-planning, engagement, and patient motivation for the long term.en
dc.language.isoeng-
dc.subjectAssessmenten
dc.subjectdiagnosisen
dc.subjectguidelinesen
dc.subjectmanagementen
dc.subjectmild cognitive impairmenten
dc.subjectprimary careen
dc.titleNationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive Impairment.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Alzheimer's Disease : JADen
dc.identifier.affiliationGrampians Health, Deakin University, Victoria, Australiaen
dc.identifier.affiliationFaculty of Health Sciences and Medicine, Bond University, Queensland, Australiaen
dc.identifier.affiliationGeneral Practitioner, NSW, Australiaen
dc.identifier.affiliationAustin Healthen
dc.identifier.affiliationCentre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australiaen
dc.identifier.affiliationDementia Australia, Parkville, Victoria, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen
dc.identifier.affiliationSchool of Psychology, The University of Sydney, New South Wales, Australiaen
dc.identifier.doi10.3233/JAD-220288en
dc.type.contentTexten
dc.identifier.pubmedid35964184-
local.name.researcherMasters, Colin L
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptAged Care-
crisitem.author.deptGeriatric Medicine-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

100
checked on Feb 16, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.